Effective cancer chemotherapy can be severely impaired by drug resistance, wherein P-glycoprotein (Pgp), a membrane protein is invovlved in effluxing cytotoxic agents from cell.
In our laboratory a pharmacophore for chemosensitizing activity was developed using Elacridar as a query molecule and based on this pharmacophore, a series of substituted 6-methoxynaphthalene-2-carboxamides were synthesized and they exhibited good Chemosensitizing activity. 4) These agents contained substituted piperazinopropyl as substituents on amide nitrogen.
Our continued interest in this area led to the development of another novel series of chemosensitizing agents. In the present work we replaced the piperazine ring by other heterocyclic systems in order to study their potential for contributing to chemosensitizing activity on evaluation. The heterocyclic systems chosen were based on their lipophilicity and their ability to act as an hydrogen bond acceptor/donor group. It is proposed to synthesise these novel molecules and evaluate them for cytotoxicity and for chemosensitizing activity in resistant cancer cell lines.
Experimental
Chemistry All melting points were recorded on Thermonik melting point apparatus and are uncorrected; fourier-transform infrared (FT-IR) spectra (KBr discs) were recorded in Jasco FT-IR 5300 instrument. Proton-NMR spectra were recorded on Varian VX-300 NMR spectrophotometer (300 MHz) using CDCl 3 and DMSO-d 6 as solvents. The chemical shift values are reported in d units (ppm) relative to internal standard tetramethylsilane (TMS). Column Chromatography was performed using Silica gel, 60-120 mesh, from Qualigens fine chemicals, India. Elemental analysis values for final compounds were within Ϯ0.4% of theoretical value.
General Method for Preparation of N-[3-(Heteroaryl)propyl]-6-methoxynaphthalene-2-carboxamides (8-13) 6-Methoxy-2-naphthoyl chloride 1 (10 mmol) was condensed with different heteroaryl propylamines 2-7 (12 mmol) in turn at room temperature in chloroform for 3-4 h to get compounds 8-13. Chloroform was removed under vacuum and the residue obtained was washed with water and then purified by column chromatography using, chloroform : ethyl acetate, 80 : 20 as eluent and then recrystallized from alcohol. Pharmacology Test compounds 8-12 were evaluated in vitro, for cytotoxicity in P388 murine lymphocytic leukemia cell line (P388) using SRB assay 4, 5) at 10, 20, 40 and 80 mg/ml concentrations (Table 1 ) and for resistance reversal activity in adriamycin resistant P388 murine lymphocytic leukemia cell line (P388/ADR) using MTT assay 4, 6) at 20 mg/ml concentrations while concentration of adriamycin used was 40 mg/ml (Table 2) . Verapamil (VRP) was used as a standard chemo-modulator and was evaluated at the same concentration as that of test compounds. Test compound 13 showed poor solubility and hence was not evaluated. All experiments were carried out in triplicates. At 40 and 80 mg/ml concentrations compounds showed significant cytotxicity and hence reversal potency was not determined at these concentrations (Table 3) .
Results and Discussion
A novel series of 6-methoxynaphthalene-2-carboxamides 8-13 with various heteroarylpropyl substituents on the amide nitrogen was synthesised by condensing 6-methoxy-2-naphthoyl chloride 1 with heteroaryl propylamines 2-7 in chloroform. Small amount of DMF was added to facilitate the reaction. The 6-methoxy-2-naphthoyl chloride 1 was prepared from the corresponding acid 4) by reacting with oxalyl chloride in dichloromethane.
The heteroaryl propylamines 2-7 were synthesized by condensing N-(3-bromopropyl)phthalimide with heterocycles like, pyrrolidine-2-one, benzimidazole, 2-methyl benzimidazole, benzotriazole, 1,2,3,4-tetrahydroisoquinoline and 4-amino-3-methylthio-5-phenyl-1,2,4-triazole in DMF in presence of base for 4-6 h at 110-120°C and cleaved by reaction with hydrazine hydrate and acidified with HCl to obtain heterocyclic propylamines. The amines were isolated by extraction in chloroform : ethyl acetate mixture (1 : 2).
The 4-amino-3-methylthio-5-phenyl-1,2,4-triazole was prepared from benzamide, by reacting it with hydrazine hydrate at 80-90°C, and the benzohydrazide formed was converted to potassium-3-benzoyl dithiocarbazate salt by stirring with carbon disulfide and potassium hydroxide in absolute alcohol at room temperature. The salt was then cyclised with hydrazine hydrate and then methylated with methyl iodide in 1 N KOH at 0°C to obtain 4-amino-3-methylthio-5-phenyl- 1,2,4-triazole. Yield 86%. mp 158-159°C. Test compounds 8-12 were evaluated for cytotoxicity in vitro in P388 cell line using SRB assay 4, 5) and were found to be nontoxic at lower doses 10 and 20 mg/ml, were slightly toxic at 40 mg/ml and more toxic at 80 mg/ml (Table 1) .
Test compounds 8-12 were then evaluated in vitro for chemosensitizing activity in P388/ADR cell line by MTT assay 4, 6) using verapamil as standard and the results are given in Tables 2 and 3 .
The percentage enhancement in adriamycin activity was calculated by the following equation:
% enhancement in ADR activityϭ100 [% inhibition of (testϩADR)Ϫ(% inhibition of ADRϩ% inhibition of test)]/% inhibition of ADR
The reversal potency was expressed by the ratio of % inhibition of (testϩADR)Ϫ(% inhibition of ADRϩ% inhibition of test) and % inhibition of ADR.
Test compounds 8-12 effectively reversed adriamycin resistance at the dose 20 mg/ml ( Table 2 ). The % enhancement in ADR activity at this concentration was in the range 70-309 and the reversal potency was in the range of 0.70-3.09, while verapamil exhibited 820% enhancement in activity with reversal potency of 8.2 at this concentration. As the test compounds 8-12 and varapamil have different molecular weights, the reversal potency values were calculated at the same molar concentrations as that of the standard (VRP) and these values are given in parentheses. At higher doses (40, 80 mg/ml) compounds showed significant cytotxicity and hence reversal potency was not determined at these concentrations (Table 3) . Finally it is observed that replacing substituted piperazines with other heterocyclic systems has led to compounds which enhanced adriamycin activity (% enhancement 70-309 at 20 mg/ml) and has reversal potency in the range 0.52-2.02 at 0.04 mmol concentration. Thus the present work has led to generation of newer structural leads, which can be further modified to reduce their inherent cytotoxicity and to enhance chemosensitizing activity.
